Bacillus Calmette-Guerin therapy after the second transurethral resection significantly decreases recurrence in patients with new onset high-grade T1 bladder cancer

BACKGROUND: The purpose of this study was to assess the efficacy of Bacillus Calmette-Guerin (BCG) therapy after a second transurethral resection (TUR) in new onset high-grade T1 bladder cancer. METHODS: From January 2008 to September 2013, 207 patients with new onset high-grade T1 bladder cancer af...

Descripción completa

Detalles Bibliográficos
Autores principales: Iida, Keitaro, Naiki, Taku, Kawai, Noriyasu, Etani, Toshiki, Ando, Ryosuke, Ikegami, Yosuke, Okamura, Takehiko, Kubota, Hiroki, Okada, Atsushi, Kohri, Kenjiro, Yasui, Takahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769574/
https://www.ncbi.nlm.nih.gov/pubmed/26920373
http://dx.doi.org/10.1186/s12894-016-0126-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769574/
https://www.ncbi.nlm.nih.gov/pubmed/26920373
http://dx.doi.org/10.1186/s12894-016-0126-x

Ejemplares similares